These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5336132)

  • 41. Management of patients with non-Hodgkin's lymphoma.
    Carbone PP
    Arch Intern Med; 1973 Mar; 131(3):455-9. PubMed ID: 4569377
    [No Abstract]   [Full Text] [Related]  

  • 42. Initial experiences with methylhydrazine, a new cytotoxic agent.
    Backhouse TW; Sicher K
    Clin Radiol; 1966 Apr; 17(2):132-5. PubMed ID: 5952323
    [No Abstract]   [Full Text] [Related]  

  • 43. Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas.
    Klener P; Donner L
    Neoplasma; 1975; 22(1):55-62. PubMed ID: 1097949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.
    Frei E; Luce JK; Talley RW; Vaitkevicius VK; Wilson HE
    Cancer Chemother Rep; 1972 Oct; 56(5):667-70. PubMed ID: 4569060
    [No Abstract]   [Full Text] [Related]  

  • 45. A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.
    Hosein PJ; Craig MD; Tallman MS; Boccia RV; Hamilton BL; Lewis JJ; Lossos IS
    Am J Hematol; 2012 Jan; 87(1):111-4. PubMed ID: 22081459
    [No Abstract]   [Full Text] [Related]  

  • 46. [Further observations concerning the results of treatment of Hodgkin's disease and lymphosarcoma with methylhydrazine].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Kolakowska-Polubiec K; Polubiec A
    Wiad Lek; 1970 Aug; 23(16):1419-22. PubMed ID: 5468885
    [No Abstract]   [Full Text] [Related]  

  • 47. BCNU (NSC-409962) in the treatment of advanced Hodgkin's disease, lymphosarcoma, and reticulum cell sarcoma.
    Rege VB; Owens AH
    Cancer Chemother Rep; 1974; 58(3):383-92. PubMed ID: 4601668
    [No Abstract]   [Full Text] [Related]  

  • 48. [Natulan (experimental and clinical data on its antitumor effect)].
    Brodskaia NA
    Vopr Onkol; 1972; 18(11):101-9. PubMed ID: 4566561
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of Hodgkin's disease in stages 3 B and IV with the chemotherapy-radiotherapy-chemotherapy sequence].
    Amiel JL; Mathé G; Tubiana M; Schlumberger JR; Rouëssé J; Pouillart P
    Bull Cancer; 1971; 58(2):191-202. PubMed ID: 4259048
    [No Abstract]   [Full Text] [Related]  

  • 50. [Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
    Goudemand M; Sautière-Habay D; Bauters F; Lerche-Habart B
    Lille Med; 1968 Dec; 13(10):1102-7. PubMed ID: 4886051
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cytostatic treatment of lymphogranulomatosis. Experiences with ibenzmethyzine, cyclophosphamide and vinblastine sulfate].
    Schubert JC; Martin H
    Munch Med Wochenschr; 1968 Jan; 110(2):97-100. PubMed ID: 5695132
    [No Abstract]   [Full Text] [Related]  

  • 52. [The cytostatic action mechanism of Natulan].
    Weitzel G; Schneider F; Kummer D; Ochs H
    Z Krebsforsch; 1968; 70(4):354-65. PubMed ID: 4233648
    [No Abstract]   [Full Text] [Related]  

  • 53. [The behavior of serum immunoglobulins in patients treated with methyl-hydrazine].
    Fazio M; Cavallero P; Sartoris S; Vergnano F
    Minerva Med; 1974 Mar; 65(22):1149-53. PubMed ID: 4406564
    [No Abstract]   [Full Text] [Related]  

  • 54. [1st experience with vinblastine therapy in lymphogranulomatosis as based on clinical and lymphographic control examinations].
    Helbig W Röder K
    Z Gesamte Inn Med; 1967 Nov; 22(22):689-95. PubMed ID: 5623735
    [No Abstract]   [Full Text] [Related]  

  • 55. [Results of polychemotherapy in neoplasms of the lymphoreticular system].
    Stenzel L; Krug K; Schingnitz G
    Z Gesamte Inn Med; 1973 May; 28(9):Suppl 9:134-6. PubMed ID: 4199963
    [No Abstract]   [Full Text] [Related]  

  • 56. [Progress in chemotherapy of solid tumors and malignant lymphomas (continued)].
    Alberto P
    Praxis; 1967 Dec; 56(49):1650-1 concl. PubMed ID: 4880021
    [No Abstract]   [Full Text] [Related]  

  • 57. [RESULTS OF CLINICAL TESTS OF A NEW CYTOSTATIC SUBSTANCE FROM THE METHYLHYDRAZINE SERIES (NATULAN)].
    BEGEMANN H; BLUM KU; FELLMER KE; FOELSCH E; GERHARTZ H; GRUNZE H; HAUSMANN K; HENNES R; JUENGLING W; KLEIBEL F; KOERTGE P; MARING H; MARTIN H; OBRECHT P; OSTEN W; PABST HW; POLIWODA H; SCHUBERT JC; SEIDL S; SPECHTER HJ; STRICKSTROCK KH; WITTE S; DREWS J
    Med Klin; 1965 Jun; 60():960-4. PubMed ID: 14304965
    [No Abstract]   [Full Text] [Related]  

  • 58. Another summer of hematology.
    Ashforth E; Cheson BD
    Clin Adv Hematol Oncol; 2010 Aug; 8(8 Suppl 16):1-19. PubMed ID: 21280260
    [No Abstract]   [Full Text] [Related]  

  • 59. [Progress in chemotherapy of solid tumors and malignant lymphomas. (1)].
    Alberto P
    Praxis; 1967 Nov; 56(48):1636-40 contd. PubMed ID: 5632585
    [No Abstract]   [Full Text] [Related]  

  • 60. [Results of cytostatic therapy of malignant hemoblastoses].
    Stacher A
    Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.